Profile
Carolyn Finkle served as Vice President of Regulatory Affairs at Imunon, Inc. She then worked as Chief Operating Officer and Head of Regulatory Affairs at Medicago, Inc. from 2019 to 2021.
Ms. Finkle also held the position of Vice President of Regulatory Affairs at Karyopharm Therapeutics, Inc. In 2022 to 2023, she served as Senior Vice President and Head of Regulatory Affairs at Applied Molecular Transport, Inc. Ms. Finkle's most recent former position was Senior Vice President and Head of Regulatory Affairs at Precigen, Inc. Ms. Finkle completed her undergraduate degree at the University of Ottawa and her graduate degree at the University of Toronto.
Former positions of Carolyn Finkle
| Companies | Position | End |
|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | General Counsel | 27/12/2023 |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Chief Operating Officer | 01/01/2021 |
| PRECIGEN, INC. | General Counsel | - |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
| IMUNON, INC. | General Counsel | - |
Training of Carolyn Finkle
| University of Ottawa | Undergraduate Degree |
| University of Toronto | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| IMUNON, INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| Private companies | 1 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Stock Market
- Insiders
- Carolyn Finkle
